Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2016 Sep 16;15(12):2894–2904. doi: 10.1158/1535-7163.MCT-16-0074

Table 1.

Body weight and fecal hemoglobin measurements from in vivo studies

SKOV3ip1 cells/nude mice Body weight (g) Fecal Hb (mg/g feces)
 Control 23.25 ± 0.71 0.32
 Aspirin-PC 22.74 ± 0.62 0.23
 Bev 22.42 ± 0.87 0.24
 Aspirin-PC/Bev 21.65 ± 0.45 0.28
ID8 cells/C57BL-6 mice
 Control 23.65 ± 0.62 0.34
 Aspirin 21.64 ± 0.32 0.34
 Aspirin-PC 21.08 ± 0.52 0.34
 B20 20.00 ± 0.13 0.26
 Aspirin/B20 19.77 ± 0.16 0.26
 Aspirin-PC/B20 19.63 ± 0.22 0.29
Hey A8 cells/nude mice
 Control 26.44 ± 0.53 0.95
 Aspirin 25.15 ± 0.65 1.75
 Aspirin-PC 24.99 ± 0.64 0.91
 Bev 26.84 ± 0.39 0.91
 Aspirin/Bev 25.15 ± 0.62 0.89
 Aspirin-PC/Bev 24.40 ± 0.67 0.93

NOTE: Body weight in grams at the termination of the study is expressed as the mean ± standard error of the mean for N=10 mice per group. Fecal hemoglobin (Hb) was measured from pooled samples collected from group cages, and is expressed as mg Hb per gram of feces for each group. For comparison, these Hb values are considered baseline and are much lower than values typically obtained from animals chronically treated with a higher dose NSAID that induces GI bleeding (ie, 2.5 to 15 mg Hb/g feces).